Quiz: The BFAST Study for Non-Small Cell Lung Cancer

December 15, 2020
Hannah Slater

In our lung cancer quiz, you’ll get to test your knowledge on the BFAST study.

What is BFAST (NCT03178552)?

a. A study investigating whether upfront brain radiotherapy is superior to “at progression” brain radiotherapy in patients with non-small cell lung cancer (NSCLC) and asymptomatic brain metastases.

b. An ongoing global study evaluating the relationship between blood-based next-generation sequencing (NGS) detection of actionable genetic alterations in circulating tumor DNA and activity of targeted therapies and immunotherapy in patients with first-line advanced NSCLC.

c. A study which assessed the effect of molecular testing and the introduction of novel therapeutic options on the use of systemic therapy and overall survival for patients with advanced NSCLC.

d. A study which evaluated the efficacy and safety of AB928 plus carboplatin, pemetrexed, and a PD-1 antibody in patients with metastatic NSCLC.